Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
| 177.24 Delayed Data As of Jun 21 |  -0.04 / -0.02%Today’s Change | 103.46 Today|||52-Week Range 189.00 | +7.39% Year-to-Date |
Latest JAZZ News | Press Releases
| 5 Fast-Growing Stocks in Gurus' Portfolios Jun 16 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 177.28 |
| Today’s open | 179.11 |
| Day’s range | 176.22 - 179.11 |
| Volume | 19,082 |
| Average volume (3 months) | 690,195 |
| Market cap | $10.8B |
Data as of 4:00pm ET, 06/21/2021
Growth & Valuation
| Earnings growth (last year) | -53.56% |
| Earnings growth (this year) | +22.95% |
| Earnings growth (next 5 years) | +16.99% |
| Revenue growth (last year) | +9.34% |
| P/E ratio | 56.1 |
| Price/Sales | 3.95 |
| Price/Book | 2.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHCValeant Pharmaceutic... | +0.03 | +0.10% |
| RGENRepligen Corp | -1.57 | -0.80% |
| UTHRUnited Therapeutics ... | +1.44 | +0.81% |
| RDYDr Reddy's Laborator... | +0.20 | +0.28% |
Data as of 4:00pm ET, 06/21/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | $3.70 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $238.6M |
| Net profit margin | 10.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
